Supernus (SUPN) traded down -3.26 % during a 24 hours period ending at 02:42 AM Central Europe on Tuesday 27th. One Supernus stock can currently be bought for about USD 40.77 on popular exchanges. Current supply of Supernus stocks is 58.2 mn. Supernus has a current market capitalization of USD 2.4 bn and approximately USD 47.2 mn worth of Supernus was traded on exchanges in the last 24 hours. Since last month end, Supernus has traded -5.98 % down. Simple moving average of last 200 days is at USD 47.54. The highest price of past 52 weeks was recorded at USD 59.68 on 02/25/2026. 52 weeks low was at USD 37.54 on 10/16/2026.
Here is how related stocks have performed in the past 24 hours:
Digi (DGII) traded up 2.95 % and now trades at USD 76.27. Digi has a market capitalisation of USD 2.8 bn. Current price/earnings ratio for Digi is 59.37.
Coty (COTY) traded up 0.62 % and now trades at USD 3.23. Current market capitalisation for Coty is USD 2.8 bn.
Customers (CUBI) traded up 7.38 % and now trades at USD 85.93. Current market capitalisation for Customers is USD 2.8 bn. Customers has a current price to earnings ratio of 10.42.
United Natural Foods (UNFI) traded down -0.85 % and now trades at USD 48.25. United Natural Foods has a market capitalisation of USD 2.8 bn. Current price/earnings ratio for United Natural Foods is 34.9.
Dnow (DNOW) traded up 1.82 % and now trades at USD 15.89. Current market capitalisation for Dnow is USD 2.8 bn.
About Supernus
Supernus Pharmaceuticals, Inc. is a specialty pharmaceutical company operating in the health care sector with its main focus on developing and marketing proprietary drugs for the treatment of central nervous system diseases and disorders. The company offers a portfolio of clinical stage drugs addressing various neurological and psychological problems such as epilepsy, conduct disorder, Parkinson’s disease, ADHD, and depression.
